Free Trial

Arrowhead Pharmaceuticals (ARWR) Insider Trading & Ownership

+0.21 (+0.85%)
(As of 05/24/2024 ET)

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Insider Buying and Selling Activity

Insider Ownership
Number Of
Insiders Buying
(Last 12 Months)
Amount Of
Insider Buying
(Last 12 Months)
Number Of
Insiders Selling
(Last 12 Months)
Amount Of
Insider Selling
(Last 12 Months)
$11.14 M
Get ARWR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Arrowhead Pharmaceuticals stock? Sign up for's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ARWR Insider Buying and Selling by Quarter

Arrowhead Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/2/2024Victoria VakienerDirectorSell1,799$23.31$41,934.69  
3/20/2024Hongbo LuDirectorBuy1,000$27.50$27,500.00  
3/18/2024Hongbo LuDirectorBuy1,000$27.49$27,490.00  
3/6/2024Kenneth Allen MyszkowskiCFOSell40,000$35.19$1,407,600.00  
1/31/2024Christopher Richard AnzaloneCEOSell57,499$32.35$1,860,092.65  
1/12/2024James C HamiltonInsiderSell7,940$36.89$292,906.60  
1/11/2024Douglas B GivenDirectorSell2,911$38.06$110,792.66  
1/5/2024James C HamiltonInsiderSell32,143$35.18$1,130,790.74  
1/5/2024Kenneth Allen MyszkowskiCFOSell16,104$35.27$567,988.08  
1/5/2024Patrick O'brienCOOSell22,841$35.27$805,602.07  
1/3/2024James C HamiltonInsiderSell6,300$32.19$202,797.00  
1/3/2024Patrick O'brienCOOSell8,749$32.28$282,417.72  
1/2/2024Christopher Richard AnzaloneCEOSell9,952$31.01$308,611.52  
12/20/2023Christopher Richard AnzaloneCEOSell12,000$28.54$342,480.00  
11/20/2023Martin Javier SanInsiderSell19,700$28.80$567,360.00  
10/25/2023Christopher Richard AnzaloneCEOSell24,338$24.21$589,222.98  
9/28/2023Victoria VakienerDirectorSell1,550$26.33$40,811.50  
9/18/2023Christopher Richard AnzaloneCEOSell57,755$28.12$1,624,070.60  
7/3/2023Tracie OliverInsiderSell8,925$35.31$315,141.75  
6/30/2023James C HamiltonInsiderSell3,000$35.53$106,590.00  
6/27/2023Kenneth Allen MyszkowskiCFOSell15,000$36.20$543,000.00  
(Data available from 1/1/2013 forward)

ARWR Insider Trading Activity - Frequently Asked Questions

Who is on Arrowhead Pharmaceuticals's Insider Roster?
What percentage of Arrowhead Pharmaceuticals stock is owned by insiders?

4.50% of Arrowhead Pharmaceuticals stock is owned by insiders. Learn more on ARWR's insider holdings.

Which Arrowhead Pharmaceuticals insiders have been buying company stock?

The following insider purchased ARWR shares in the last 24 months: Hongbo Lu ($54,990.00).

How much insider buying is happening at Arrowhead Pharmaceuticals?

Insiders have purchased a total of 2,000 ARWR shares in the last 24 months for a total of $54,990.00 bought.

Which Arrowhead Pharmaceuticals insiders have been selling company stock?

The following insiders have sold ARWR shares in the last 24 months: Adeoye Y Olukotun ($370,577.50), Christopher Richard Anzalone ($6,874,359.67), Douglas B Given ($405,185.16), James C Hamilton ($2,646,088.98), Kenneth Allen Myszkowski ($3,743,588.08), Martin Javier San ($1,152,165.00), Patrick O'brien ($2,319,644.79), Tracie Oliver ($315,141.75), Victoria Vakiener ($82,746.19), and William D Waddill ($96,000.00).

How much insider selling is happening at Arrowhead Pharmaceuticals?

Insiders have sold a total of 532,125 Arrowhead Pharmaceuticals shares in the last 24 months for a total of $18,005,497.12 sold.

More Insider Trading Tools from MarketBeat

This page (NASDAQ:ARWR) was last updated on 5/25/2024 by Staff

From Our Partners